The Certified Medical Representatives Institute Inc., Roanoke, VA, has added three new self-study courses to its continuing education program for pharmaceutical sales representatives.
The Certified Medical Representatives Institute Inc., Roanoke, VA, has added three new self-study courses to its continuing education program for pharmaceutical sales representatives.
"Diabetes: Approaches in Disease Management" addresses the clinical and economic impact of diabetes management, profiles current treatment guidelines and describes the different diabetes management programs being developed by pharmaceutical companies.
"Contemporary Pharmacoeconomics" describes pharmacoeconomic research methods and their applications in health care. It encompasses the relationship between disease management, outcomes management, pharmacoeconomics and quality-of-life surveys, as well as the role of pharmacoeconomics in formulary decision-making.
"Outcomes Measurement, Management and Marketing" presents an overview of outcomes research and management in the health care delivery process and how outcomes data can be used as a valuable selling tool. It also explains how and why some pharmaceutical companies are partnering with managed care organizations to conduct outcomes research.
The courses are self-directed and approved for credit toward CMR certification. Representatives who wish to be certified by CMR may concentrate in one of three areas of study: business in health care, disease management or science and medicine.
For more information, call (800) 274-2674. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.